Phase 3 Cardiovascular Diseases trials recruiting now

All Cardiovascular Diseases trials, every phase

Other phases for Cardiovascular Diseases

Phase 3 Cardiovascular Diseases trials

• A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
  NCT07816185 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 3 locations
• COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
  NCT05633810 · Phase: Phase 3 · Ages: 55 Years to 80 Years · Sex: All (male and female) · 39 locations
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1147 locations
• Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
  NCT07613099 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
  NCT06082063 · Phase: Phase 3 · Ages: 40 Years to 90 Years · Sex: All (male and female) · 2 locations
• PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
  NCT04971720 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.